Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
---|---|---|---|---|
|
|
Health: Unknown
Source: human faeces (Tohya2019)
DNA G+C(%): 62.3
|
Opt. T: 30℃
Low T(℃): 4(+)
Mid T(℃): 40(+)
NaCl 0.5-2%: 0.5(+)
NaCl >6%: 5.5(+)
|
|
Monosaccharide util/assim | Oligosaccharide util/assim | Other carboh. util/assim | Amino acid util/assim | Organic acid util/assim |
---|---|---|---|---|
|
|
|
|
|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
---|---|---|---|---|
|
|
|
|
|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
---|---|---|---|---|
|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
---|---|---|---|---|
imipenem: R(16-256)
meropenem: R(32-1024)
|
cefepime: R(16-512)
ceftazidime: R(32->2048)
|
amikacin: RNG: (≤4-256)
gentamicin: RNG: (1-256)
tobramycin: RNG: (≤0.5-512)
|
|
ciprofloxacin: RNG: (≤0.5-256)
|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
|
|
|
|
colistin: SensRNG: (≤0.5-2)
|